News for Amicus Therapeutics, Inc. (AM6.F)

24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Carnival, Norwegian Cruise Lines, Royal Caribbean and Switch.

The following slide deck was published by Amicus Therapeutics, Inc.

2020 Total Galafold Revenue of $260.9M; Increased 43 Percent Year-on-Year Continued Strong Global Growth of Galafold Expected in 2021 with...

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

Stocks that traded heavily or had substantial price changes Friday: Newell Brands, Amicus fall; HubSpot, Cognex rise

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Top Line Results From the PROPEL Phase 3 Study Comparing AT-GAA Versus alglucosidase alfa/placebo In Late Onset Pompe ... | February 12, 2021

Upgrades According to Citigroup, the prior rating for YETI Holdings Inc (NYSE:YETI) was changed from Neutral to Buy. In the fourth quarter, YETI Holdings ...

Shares of Amicus Therapeutics Inc. undefined were down 23.1% in premarket trading on Friday, the day after the company said an experimental rare disease drug...

The following slide deck was published by Amicus Therapeutics, Inc.

Top Insider Buys Highlight for the Week of Jan. 8, Stocks: PRGO,CODI,GBDC,FOLD, release date:Jan 10, 2021